These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24105052)

  • 1. [Chemotherapy for malignant gliomas: an update].
    Wakabayashi T; Natsume A; Fujii M
    Gan To Kagaku Ryoho; 2013 Oct; 40(10):1283-7. PubMed ID: 24105052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy.
    Silber JR; Blank A; Bobola MS; Ghatan S; Kolstoe DD; Berger MS
    Clin Cancer Res; 1999 Apr; 5(4):807-14. PubMed ID: 10213216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.
    Pollack IF; Hamilton RL; Sobol RW; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL
    J Clin Oncol; 2006 Jul; 24(21):3431-7. PubMed ID: 16849758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical trial updates for malignant brain tumors].
    Wakabayashi T
    Rinsho Shinkeigaku; 2011 Nov; 51(11):853-6. PubMed ID: 22277391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical trial of MCNU for malignant brain tumors].
    Harada K; Okamoto H; Fujioka Y; Uozumi T; Kiya K; Kitaoka T; Goishi A; Sasaki U; Shima T; Inagawa T
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1423-31. PubMed ID: 2990350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model.
    Towner RA; Ihnat M; Saunders D; Bastian A; Smith N; Pavana RK; Gangjee A
    BMC Cancer; 2015 Jul; 15():522. PubMed ID: 26177924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of ACNU alone and combined with tegafur as additions to radiotherapy of the treatment of malignant gliomas--a cooperative clinical trial].
    Ushio Y; Abe H; Suzuki J; Tanaka R; Kitamura K; Miwa T; Matsutani M; Takeuchi K; Takakura K; Nomura K
    No To Shinkei; 1985 Oct; 37(10):999-1006. PubMed ID: 3000412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of O6-methylguanine-DNA methyltransferase gene expression in gliomas by platinum compounds.
    Tanaka S; Kobayashi I; Utsuki S; Oka H; Yasui Y; Fujii K
    Oncol Rep; 2005 Nov; 14(5):1275-80. PubMed ID: 16211296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiles predicting the response to IFN-β and a combination of temozolomide and IFN-β in malignant gliomas.
    Yoshino A; Tashiro S; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Sano E; Tsumoto K
    Int J Oncol; 2011 Sep; 39(3):529-42. PubMed ID: 21805051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in the treatment of malignant gliomas.
    Soffietti R; Leoncini B; Rudà R
    Expert Rev Neurother; 2007 Oct; 7(10):1313-26. PubMed ID: 17939769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis in malignant glioma--a target for antitumor therapy?
    Tuettenberg J; Friedel C; Vajkoczy P
    Crit Rev Oncol Hematol; 2006 Sep; 59(3):181-93. PubMed ID: 16860996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cytotoxic drugs in the treatment of central nervous system gliomas.
    Neyns B; D'haeseleer M; Rogiers A; Van de Cauter J; Chaskis C; Michotte A; Strik H
    Acta Neurol Belg; 2010 Mar; 110(1):1-14. PubMed ID: 20514922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.
    Norden AD; Young GS; Setayesh K; Muzikansky A; Klufas R; Ross GL; Ciampa AS; Ebbeling LG; Levy B; Drappatz J; Kesari S; Wen PY
    Neurology; 2008 Mar; 70(10):779-87. PubMed ID: 18316689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-angiogenic therapy for malignant glioma].
    Nagane M
    Gan To Kagaku Ryoho; 2014 Feb; 41(2):141-7. PubMed ID: 24743191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical treatment of high grade malignant gliomas in adults: an overview.
    Brandes A; Soesan M; Fiorentino MV
    Anticancer Res; 1991; 11(2):719-27. PubMed ID: 2064325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
    Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary individual adjuvant therapy for gliomas based on the results of molecular biological analyses for drug-resistance genes.
    Tanaka S; Kamitani H; Amin MR; Watanabe T; Oka H; Fujii K; Nagashima T; Hori T
    J Neurooncol; 2000; 46(2):157-71. PubMed ID: 10894369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of chemotherapy in the treatment of low-grade glioma. A review of the literature.
    Neyns B; Sadones J; Chaskis C; De Ridder M; Keyaerts M; Veld PI; Michotte A
    Acta Neurol Belg; 2005 Sep; 105(3):137-43. PubMed ID: 16255151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for high-grade gliomas of childhood.
    Pollack IF; Boyett JM; Finlay JL
    Childs Nerv Syst; 1999 Oct; 15(10):529-44. PubMed ID: 10550584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.